Tuesday, 2 July 2019
Morning
Biopharmaceutical manufacturing and single-use technologies: Process intensification and continuous bioprocessing
09:00 - 09:30 | Registration and coffee |
Session chair | Cathy Kroll, CEO of swiTT Swiss Technology Transfer Association, CH |
09:30 - 09:50 | Welcome message Urs Hilber, Zurich University of Applied Sciences, CH |
09:50 - 10:35 | Single-use technologies in biopharmaceutical manufacturing: A 10-year review of trends; how SUS is shaping the future of bioprocessing Eric Langer, BioPlan Associates, Inc., USA |
10:35 - 11:20 | Single-use process intensification: An introduction Stefan R. Schmidt, BioAtrium AG, CH |
11:20 - 13:00 | Lunch, exhibition and poster session |
Noon, Parallel session 1
Intensified single-use bioprocessing
Session chair | Regine Eibl, ZHAW, CH |
13:00 - 13:30 | Design considerations towards an intensified single-use facility Gerben Ziljstra, Sartorius Stedim Biotech GmbH, DE |
13:30 - 14:00 | Seed train process intensification by using a high-cell density crysopreservation approach Habib Horry, Merck KGaA, DE |
14:00 - 14:30 | Enhanced single-use bioreactors equipment for scale-up, process intensification and continuous bioprocessing Nephi Jones, Thermo Fisher Scientific, USA |
14:30 - 15:00 | Bioreactors for 3D printing? How additive manufacturing can influence the design and manufacturing of single-use bioreactors Stephan C. Kaiser, Thermo Fisher Scientific, USA |
15:00 - 15:30 | Coffee break and exhibition |
Noon, Parallel session 2
Data driven process development and optimization with single-use devices
Session chair | Christina Fritz, Roche Diagnostics GmbH, DE |
13:00 - 13:30 | Importance of digital technologies in modern biomanufacturing William G. Whitford, GE Healthcare, USA |
13:30 - 14:00 | Data science and PAT tools for the bioprocess life cycle Christoph Herwig, Technical University Vienna, AUT |
14:00 - 14:30 | Smart digital solution based development of processes with single use bioprocesses Peter Neubauer, Bioprocess Engineering, TU Berlin, DE, Michael Sokolov, Datahow AG, CH |
14:30 - 15:00 | Workflow for model-assisted design and scale-up of biopharmaceutical production processes Johannes Möller, Technical University Hamburg, DE, Jan Müller, ZHAW, CH |
15:00 - 15:30 | Coffee break and exhibition |
Afternoon, Parallel session 3
Continuous biomanufacturing
Session chair | Diego Schmidhalter, Lonza, CH |
15:30 - 16:00 | Single-use systems in biopharmaceutical manufacturing - regulatory considerations Daniel Müller, Leitstelle Arzneimittelüberwachung Baden-Württemberg (GMP Inspectorate), Regierungspräsidium Tübingen, DE |
16:00 - 16:30 | MoBiDiK – Comparability and regulatory aspects of continuous DSP Martin Lobedann, Bayer AG, DE |
16:30 - 17:00 | Intensified bioproduction via combination of unit operations and PAT Detlef Eisenkrätzer, Pharma Technical Development Europe, Roche Diagnostics GmbH, DE |
17:00 - 17:30 | Single-use continuous downstream processing for biopharmaceutical products Britta Manser, Pall International, CH |
17:30 - 19:00 | Exhibition and poster session |
Job market | |
17:40 - 17:55 | Lonza AG, CH Stefanie Beck, Lonza: High-end science and technology in the middle of the alps |
17:55 - 18:10 | VTU Group GmbH, AUT Thomas Viertel, Join-VTU - an opportunity to shape the future of the Life Sciences Industry |
18:10 - 18:25 | Werthenstein Biopharma GmbH, CH Markus Tanner, Werthenstein Biopharma GmbH |
19:30 – 23:00 | Conference dinner (boat trip on Lake Zurich) |
Afternoon, Parallel session 4
New modular and flexible single-use facilities
Session chair | Stefan Junne, Technical University Berlin, DE |
15:30 - 16:00 | Changing from stainless steel to single-use in biopharmaceutical production: Implications for the facility design Wolfgang Minas, Chemgineering Technology AG, CH |
16:00 - 16:30 |
A new 2kL hybrid single-use multiproduct drug substance manufacturing facility Sven Kiesewetter, Bideco AG, CH |
16:30 - 17:00 | The iCON cell therapy platform Paul Clarke, G-CON, IE |
17:00 - 17:30 | New aseptic fill finish facility for the production of potent drug products (DP) Rainer Glöckler, Swissfillon AG, CH |
17:30 - 19:00 | Exhibition and poster session |
Job market | |
17:40 - 17:55 | Lonza AG, CH Stefanie Beck, Lonza: High-end science and technology in the middle of the alps |
17:55 - 18:10 | VTU Group GmbH, AUT Thomas Viertel, Join-VTU - an opportunity to shape the future of the Life Sciences Industry |
18:10 - 18:25 | Werthenstein Biopharma GmbH, CH Markus Tanner, Werthenstein Biopharma GmbH |
19:30 – 23:00 | Conference dinner (boat trip on Lake Zurich) |
Online registration for the conference will be open until 25th June 2019.